Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,277 | 35,622 | 33,358 | 124,968 | 422,765 |
| Marketable Securities | 408,303 | 417,481 | 439,662 | 406,752 | 135,618 |
| Receivables | 16,697 | 19,669 | 18,054 | 13,876 | 8,695 |
| Inventories | 7,061 | 6,543 | 3,565 | 3,321 | 2,735 |
| TOTAL | $489,971 | $494,428 | $508,651 | $562,330 | $580,996 |
| Non-Current Assets | |||||
| PPE Net | 2,227 | 2,317 | 2,508 | 2,285 | 904 |
| Intangibles | 18,815 | 19,610 | 20,405 | 15,630 | 16,216 |
| Other Non-Current Assets | 2,767 | 2,682 | 2,792 | 2,543 | 2,691 |
| TOTAL | $23,809 | $24,609 | $25,705 | $20,458 | $19,811 |
| Total Assets | $513,780 | $519,037 | $534,356 | $582,788 | $600,807 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,778 | 5,090 | 2,540 | 3,262 | 3,017 |
| Accrued Expenses | 48,210 | 44,131 | 43,641 | 68,625 | 35,189 |
| TOTAL | $56,466 | $51,221 | $47,879 | $73,451 | $39,745 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,317 | 1,847 | 1,636 | 1,554 | 1,462 |
| Other Non-Current Liabilities | 3,493 | 3,611 | 3,615 | 3,353 | 2,538 |
| TOTAL | $6,446 | $6,982 | $6,965 | $6,586 | $5,599 |
| Total Liabilities | $62,912 | $58,203 | $54,844 | $80,037 | $45,344 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,676 | 102,432 | 101,363 | 101,355 | 100,846 |
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Retained earnings | -640,125 | -620,399 | -590,077 | -554,081 | -488,367 |
| Other shareholders' equity | 69 | -92 | -52 | 84 | -6 |
| TOTAL | $450,868 | $460,834 | $479,512 | $502,751 | $555,463 |
| Total Liabilities And Equity | $513,780 | $519,037 | $534,356 | $582,788 | $600,807 |